Molecular Medicine Flashcards

1
Q

molecular medicine

definition

A

application of molecular bio + biochem + genetics to diagnosis and treatment of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

common cause of breast/ovarian cancer

A

BRCA1/2 mutations
breast lifetime risk w/mutation= 45-85%
ovarian lifetime risk w/mutation= 39-46% (1) or 10-27% (2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PCR

A

amplify DNA by sep template strands then bind oligonucleotides (primers) for polymerase to extend/amplify b/t primers

shows known polymorphisms in selected regions, single genes/locus

olig can be allele specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

whole genome sequence

A

shows all SNPs, all mutations

more affordable and widely used, but remember 99% genome not expressed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

exome

A

aka exon portion, the 1% of the genome that is actually expressed

whole exome sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

allele specific arrays

A

oligonucleotides bind just to WT or mutant sequence then fragment and label DNA

detect label by hybridization to mutant ASO indicates presence of mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DNA sequencing

A

determine nucleotide sequencing

  1. di-deoxy chain termination method - classic but only 1000 bp/reaction
  2. next generation sequencing - miniaturization of reactions, larger sequence length but challenging to reconstruct
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SNP typing

A

only bits of genome that are known to vary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DNA methylation sequencing

A

bisulfite sequencing (coverts C to U) then PCR converts (U to T)

C bases that were converted to T were NOT methylated in og sample

tissue specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

FISH

A

hybridize labelled DNA probe to genomic DNA in interphase nucleus
-should be 2 fluorescent sites for autosomal loci
-3 loci = region is present in 3 copies (trisomy)
-1 loci = one copy (monosomy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cancer-MGPT

A

MGPT (multigene panel testing) to determine seq of known oncogenes and tumor suppressors

classifications: pathogenic, likely patho, uncertain significance, likely benign, benign

can predict risk/prognosis/suggest treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

prenatal diagnosis techniques

A
  1. chromosome analysis i.e karyotype/FISH (detects numerical and structural aberrations)
  2. exome sequencing (when karyotype is normal, single gene disorders)
  3. cell free fetal (maternal)

turnaround time critical for reprod decisions and intrauterine intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharmacogenomics

A

develop an indiv drug treatment plan but response hard to predict with accuracy

i.e Warfarin (oral anticoagulant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Warfarin

A

inhibits vitamin K epoxide reductase (VKORC1) so polymorphism affects sensitivity

metabolized by P450 enzyme (CYP2C9) so polymorphism affects sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

considerations before testing

A
  1. what to do with info aka will it help prevent disease or worry pt
  2. who will have access- HIPAA, GINA (genetic discrim protection in employment and health insurance)
  3. incidental findings
  4. ethics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

qRT-PCR

A

for RNA analysis, normal PCR not work
-reverse transcriptase (RNA > cDNA)

shows amount of a few select RNA molecules in sample

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

BRCA1 185delAG analysis

A

RNA missing 2 nucleotides
-transcript still presesnt
-not truncated transcript from stop codon

18
Q

protein analysis

A

use antibodies bc bind to antigens/proteins with high specificity

label/trace/precipitate antibodies

19
Q

monoclonal antibody production

A
  1. challenge an animal w/ antigen aka inject into a mouse
  2. isolate B cells (from spleen)
  3. fuse B cells with immortal myeloma cells (cancer cells)
  4. sep hybridoma cells
  5. select clone that produces best antibody
20
Q

ELISA

enzyme linked immuno sorbent assay

A

assay highly quantitative for proteins, not size or localization

sandwich ELISA for id antigens OR
indirect ELISA for id antibodies

21
Q

blotting technique

A

DNA (southern) or RNA (north) or proteins (western)
-shows size well and quantity (not as well)

  1. sep molecules in a gel
  2. transfer blot onto membrane
  3. detect molecule of interest
22
Q

western blotting

A

shows if protein is properly glycosylated (makes protein bigger)
or protein is cleaved

23
Q

mass spectroscopy

small molecules/metabolites

A

small moles ionized and sep by size

detector shows extremely accurate molecular weight so molecules id by weight

24
Q

molecular therapies

A

either target genes (replace defective or insert new) or proteins (antibodies destroy malignant cells)

25
Q

gene therapy

goal

A

aim to insert a functional copy of defective gene into genome thru viruses (DNA)

inc specificity with CRISPR/cas9 guide RNA

26
Q

gene therapy delivery system

A

must be efficient to reach as many cells as possible but safely
-cannot trigger fatal immune respone or transform into cancer cells

27
Q

ADA deficiency

A

adenosine deaminase deficiency = xs cellular dATP > inhibit DNA syn = SCID

recessive disorder so ideal for gene therapy bc will dissapear if heterozygous state

28
Q

ex vivo gene therapy

A
  1. isolate T cells from pt
  2. transfect w/ virus carrying normal gene (ex. ADA)
  3. select transfected T cells
  4. infuse pt
  5. test pt immune response
29
Q

CART

chimeric antigen receptor T cells

A

genetically engineered T cells detect and destroy cancer cells
-T cells from pt > transfect w/ lentiviral vector = chimeric receptor for tumor cell antigen so CART cells recognize lymphoblasts

acute lymphoblastic leukemia treatment

30
Q

cancer immunotherapy

naked antibodies

A

naked antibodies
1. bind to tumor cells and attract immune cells to destroy cancer
2. unblock immmune system
3. block receptors on cancer to shut off growth signals

31
Q

cancer immunotherapies

conjugated antibodies

A

can be radiolabelled or chemo-labelled to deliver cytotoxic drug into center of tumor

32
Q

karyotype analysis

A

only on nucleated dividing cells from amniotic fluid or chorionic villi

culture and stop in metaphase for test (2 weeks)

time consuming and expensive

33
Q

aneploid pregnancies

A

45, X + trisomy 18 + 13 usually lost
XXX/XXY/XYY + trisomy 21 chance to come to term (greater than 60%)

34
Q

complications of down syndrome

A
  1. congenital heart defect
  2. bowel obstruction
  3. hearing loss
  4. spinal problems
  5. eye abnormal
  6. leukemia and polycythemia
  7. cognitive impairment
  8. risk for alzheimer
35
Q

causes of down syndrome

A
  1. free trisomy 21 (nondisjunction, low recurrence, majority)
  2. translocation (recombination 14/21, high recurrence, aka familial DS)
  3. mosaicism (nondisjuction, low recurrence, unclear outcome)
36
Q

edwards syndrome

A

full trisomy 18

characteristic ultrasound findings

serious physical/mental disabilities
-heart defects can be surgery

second most common trisomy

37
Q

gynecomastia

A

hx of behavior problems(societal, not genetic), normal IQ, learning disabilities

-microordchidism + tall (95th percentile) + dev breast + high pitched voice
-infertile (azoospermia)

47, XXY (extra x/barr body, active Y so male)

klinefelter syndrome

38
Q

turner syndrome

A

infant: low posterior hairline + webbed neck + lymphedema + cardiac murmur

child: short, shield chest (SHOX), ovarian failure, horseshoe kidney, coarctation of aorta

45, X (affects females, high fetal loss from lymphatetic malformation)

39
Q

viable aneuploides

A

trisomy 21- down syndrome, most common
trisomy 18- edwards syndrome, rare but 10% survive
45,X - females, turners syndrome
47, XXY- male, klinefelter syndrome

40
Q

fragile X syndrome

A

CGG triplet expansion in 5’UTR of FMR1 gene (beyond 200 units = silence of FMR1 locus via methylation)

evident only in folate deficient media, use PCR or southern blotting

2nd most common cause of ID (down syn is 1st)